Detection of parvovirus B19-specific IgM by antibody capture radioimmunoassay

Area of Science:

• Immunology
• Virology
• Diagnostic Assays

Background:

• Parvovirus B19 infections require accurate diagnostic methods for timely treatment.
• Existing diagnostic approaches may have limitations in detecting recent acute infections.
• Immunoglobulin M (IgM) is a key indicator of recent viral exposure.

Purpose of the Study:

• To describe a novel solid phase IgM-capture radioimmunoassay (MACRIA) for detecting parvovirus B19-specific IgM.
• To establish a quantitative method for diagnosing recent acute parvovirus B19 infection.

Main Methods:

• Serum IgM is captured using anti-human IgM immobilized on a solid phase.
• Detection involves adding parvovirus B19 antigen, followed by a detector system.
• The detector system utilizes a mouse monoclonal antibody to parvovirus B19 and a radiolabeled anti-mouse antibody (125I).

Main Results:

• The MACRIA protocol allows for the quantification of parvovirus B19-specific IgM.
• A calibration curve using standard B19 IgM serum enables single-dilution quantification of test sera.
• The assay is designed for the specific detection of IgM indicative of recent parvovirus B19 infection.

Conclusions:

• The described MACRIA is an effective method for identifying parvovirus B19-specific IgM.
• This assay provides a reliable tool for the diagnosis of recent acute parvovirus B19 infections.
• The quantitative nature of the assay enhances its clinical utility in parvovirus B19 diagnostics.